1. The GAIA (CLL13) trial – an international, randomized, four-arm study for first line treatment of physically fit CLL patients without del17p or TP53 mutation. Issue 5 (2017) Authors: J, Von Tresckow; J, Bahlo; CU, Niemann; AP, Kater; AM, Fink; , Fischer K; , Ritgen M; , Kreuzer KA; , Stilgenbauer S; R, van Oers; C, Hartmann Geisler; , Hallek M; B, Eichhorst Journal: Integrative cancer science and therapeutics Issue: Volume 4:Issue 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗